Accessibility Menu
Stevanato Group S.p.A. logo

Stevanato Group S.p.A.(NYSE) STVN

Market Cap$5.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+5%
5 Year-0%
1 Year-16%
1 Month+5%
$20.34
+0.25%
+0.05Today
After hours$20.30-$0.04 (-0.20%)
Stevanato Group S.p.A. last closing stock price
MetricPriceDate
Last closeUSD 20.272026-08-07
Stevanato Group S.p.A. stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.12%USD 19.852026-07-31
1 month+4.92%USD 19.322026-07-08
3 month+11.59%USD 18.162026-05-08
Year to date+1.11%USD 20.052025-12-31
1 year-15.94%USD 24.112025-08-07
3 year-42.35%USD 35.162023-08-08
5 year-0.22%USD 20.312021-08-06
Since inception+4.6%USD 19.382021-07-16

Stevanato Group S.p.A. Financials at a Glance

Market Cap

$5.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.20B

Net Income (TTM)

€140.95M

EPS (TTM)

$0.58

P/E Ratio

35.24

Dividend

$0.06

Beta (Volatility)

0.92 (Low)

Price

$20.34

Volume

306,404

Open

$20.05

Previous Close

$20.27

Daily Range

$19.95 - $20.42

52-Week Range

$12.89 - $28.00

Estimated Earnings Date

Nov 5, 2026

STVN News

No articles available.

STVN: Motley Fool Moneyball Superscore

59

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stevanato Group S.p.A.

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Established in 1949, the company offers a diverse range of products, including containment solutions, drug delivery systems, and medical devices.

Products and Services
  • Containment solutions for pharmaceuticals
  • Drug delivery systems and medical devices
  • Specialized machinery for packaging and inspection
Growth Outlook
  • Projected revenue growth driven by increasing demand in healthcare
  • Expansion into emerging markets to enhance market presence
  • Investment in R&D to innovate and improve product offerings
Financial Highlights
  • Q1 2026 revenue of €273.57 million, reflecting strong market demand
  • Net income of €28.03 million in Q1 2026, showcasing profitability
  • Trailing twelve months (TTM) gross profit margin of 29%, indicating operational efficiency
Stevanato Group S.p.A. operates in the medical instruments and supplies industry, focusing on high-quality solutions that cater to the evolving needs of the pharmaceutical sector. The company has demonstrated resilience and adaptability, positioning itself for future growth through strategic investments and a commitment to innovation. Recent financial performance highlights a solid revenue base and profitability, which may attract potential investors looking for opportunities in the healthcare sector. The company's ongoing efforts to expand its product line and market reach further enhance its growth potential, making it a noteworthy consideration for investment.
AI Generated • Jul 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Franco Stevanato

Website

www.stevanatogroup.com

Headquarters

Piombino Dese, PD 35017, IT

STVN Financials

Key Financial Metrics (TTM)

Gross Margin

29.01%

Operating Margin

16.57%

Net Income Margin

11.75%

Return on Equity

9.63%

Return on Capital

9.36%

Return on Assets

5.46%

Earnings Yield

2.84%

Dividend Yield

0.31%

Payout Ratio

0.04%

Stock Overview

Market Cap

$5.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

273.00M

Volume

306.40K

Avg. Volume

362.36K

Financials (TTM)

Gross Profit

€348.16M

Operating Income

€198.80M

EBITDA

€294.22M

Operating Cash Flow

€260.08M

Capital Expenditure

-€267.18M

Free Cash Flow

-€7.11M

Cash & ST Invst.

€112.73M

Total Debt

€448.52M

Stevanato Group S.p.A. Performance Analysis

Stevanato Group S.p.A. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,033,822,4163.6%
20232023-12-31EUR 1,173,393,14413.5%
20242024-12-31EUR 1,194,225,5361.8%
20252025-12-31EUR 1,338,811,70812.1%
Stevanato Group S.p.A. sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-309.1%
Q32025-09-308.3%
Q42025-12-3113.2%
Q12026-03-31-20.3%
Stevanato Group S.p.A. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.57-5.4%
20232023-12-31EUR 0.594.8%
20242024-12-31EUR 0.47-20.9%
20252025-12-31EUR 0.5823.1%
Stevanato Group S.p.A. sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3010.0%
Q32025-09-3018.2%
Q42025-12-3130.8%
Q12026-03-31-41.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€273.57M

+6.6%

Gross Profit

€75.18M

+7.6%

Gross Margin

27.48%

N/A

Market Cap

$5.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$920.76K

N/A

Employees

6,010

N/A

Net Income

€28.03M

+5.7%

EBITDA

€65.06M

+13.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€112.73M

+24.3%

Total Debt

€448.52M

+14.0%

Accounts Receivable

€506.66M

+3.9%

Inventory

€294.36M

+12.5%

Long Term Debt

€323.76M

+3.5%

Short Term Debt

€124.75M

+54.7%

Return on Assets

5.46%

N/A

Return on Invested Capital

9.82%

N/A

Free Cash Flow

€4.77M

-83.0%

Operating Cash Flow

€75.49M

-24.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MMSIMerit Medical Systems, Inc.
$89.04+1.54%
TFXTeleflex Incorporated
$134.98-2.82%
BLCOBausch + Lomb Corporation
$16.78+2.63%
CHEChemed Corporation
$552.72+0.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About STVN

What is the current price of Stevanato Group S.p.A.?

Stevanato Group S.p.A. is trading at $20.27 per share.

What is the 52-week range for Stevanato Group S.p.A.?

Over the past 52 weeks, Stevanato Group S.p.A. has traded between $12.89 and $28.00.

How much debt does Stevanato Group S.p.A. have?

As of the most recent reporting period, Stevanato Group S.p.A. reported total debt of €506.47M.

How much cash does Stevanato Group S.p.A. have on hand?

Stevanato Group S.p.A. reported €89.91M in cash and cash equivalents in its most recent financial results.

What is Stevanato Group S.p.A.’s dividend yield?

Stevanato Group S.p.A. currently has a dividend yield of 0.31%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services